IL144127A0 - Pharmaceutical compositions containing a carboxylic acid secondary amide derivative - Google Patents

Pharmaceutical compositions containing a carboxylic acid secondary amide derivative

Info

Publication number
IL144127A0
IL144127A0 IL14412799A IL14412799A IL144127A0 IL 144127 A0 IL144127 A0 IL 144127A0 IL 14412799 A IL14412799 A IL 14412799A IL 14412799 A IL14412799 A IL 14412799A IL 144127 A0 IL144127 A0 IL 144127A0
Authority
IL
Israel
Prior art keywords
carboxylic acid
pharmaceutical compositions
compositions containing
secondary amide
amide derivative
Prior art date
Application number
IL14412799A
Other languages
English (en)
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Publication of IL144127A0 publication Critical patent/IL144127A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14412799A 1999-01-07 1999-12-16 Pharmaceutical compositions containing a carboxylic acid secondary amide derivative IL144127A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/226,693 US6207700B1 (en) 1999-01-07 1999-01-07 Amide derivatives for antiangiogenic and/or antitumorigenic use
PCT/US1999/030220 WO2000040088A1 (en) 1999-01-07 1999-12-16 Amide derivatives for antiangiogenic and/or antitumorigenic use

Publications (1)

Publication Number Publication Date
IL144127A0 true IL144127A0 (en) 2002-05-23

Family

ID=22850011

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14412799A IL144127A0 (en) 1999-01-07 1999-12-16 Pharmaceutical compositions containing a carboxylic acid secondary amide derivative
IL144127A IL144127A (en) 1999-01-07 2001-07-03 Pharmaceutical preparations containing a secondary rich history of carboxylic acid

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL144127A IL144127A (en) 1999-01-07 2001-07-03 Pharmaceutical preparations containing a secondary rich history of carboxylic acid

Country Status (12)

Country Link
US (2) US6207700B1 (de)
EP (1) EP1146788B1 (de)
JP (1) JP2002534362A (de)
CN (1) CN1195515C (de)
AT (1) ATE362758T1 (de)
AU (1) AU760555B2 (de)
BR (1) BR9916800A (de)
CA (1) CA2358289C (de)
DE (1) DE69936150T2 (de)
ES (1) ES2288039T3 (de)
IL (2) IL144127A0 (de)
WO (1) WO2000040088A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200100302A (et) * 1998-12-02 2002-08-15 Pfizer Products Inc. Meetodid ja kompositsioonid p53 perekonna valgu konformatsioonilise stabiilsuse taastamiseks
EP1307585B1 (de) * 2000-08-07 2009-01-21 Vanderbilt University Zusammensetzungen und verfahren zum nachweis und zur quantifizierung von cox-2-aktivität und 2-arachidonylglycerin-metaboliten
AR030345A1 (es) * 2000-08-14 2003-08-20 Alcon Inc Metodo de tratamiento de desordenes relacionados con angiogenesis
EP1313697B1 (de) 2000-08-29 2005-11-30 Nobex Corporation Immunoregulierende verbindungen, deren derivate und ihre verwendung
WO2002053534A1 (en) * 2000-12-28 2002-07-11 Daiichi Pharmaceutical Co., Ltd. Vla-4 inhibitors
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
WO2003073988A2 (en) 2002-02-28 2003-09-12 A & D Bioscience, Inc. Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof
WO2003079980A2 (en) * 2002-03-19 2003-10-02 A & D Bioscience, Inc. Caboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof
WO2003086475A1 (en) * 2002-04-12 2003-10-23 A & D Bioscience, Inc. Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents, and uses thereof
WO2003094842A2 (en) * 2002-05-07 2003-11-20 A & D Bioscience, Inc. Conjugates comprising central nervous system active drug
US20050215487A1 (en) * 2002-06-27 2005-09-29 Holick Michael F Conjugates comprising an nsaid and a sugar and uses thereof
JP2006524239A (ja) * 2003-03-27 2006-10-26 メルク　エンド　カムパニー　インコーポレーテッド 高眼圧症を治療するための眼用組成物
WO2005002293A2 (en) * 2003-06-25 2005-01-06 Vanderbilt University Cox-2-targeted imaging agents
CA2528586A1 (en) 2003-07-24 2005-02-03 Daiichi Pharmaceutical Co., Ltd. Cyclohexanecarboxylic acid compound
CA2563617A1 (en) * 2004-04-20 2005-11-03 Rnd Pharmaceuticals Pharmaceutical compositions and methods of use of lipophilic, silicon-substituted, cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs and derivatives
US7491744B2 (en) * 2004-04-26 2009-02-17 Vanderbilt University Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity
JP2005343802A (ja) * 2004-05-31 2005-12-15 Norifumi Sakayama 非ステロイド性消炎鎮痛剤の外用剤を用いた癌細胞の増殖を抑制する方法
EP1773767B1 (de) 2004-07-07 2016-03-09 Biocon Limited Synthese von azogebundenen, das immunsystem regulierenden verbindungen
AU2006204523A1 (en) * 2005-01-04 2006-07-13 Novartis Ag X-ray structure of human FPPS and use for selecting FPPS binding compounds
WO2007005941A2 (en) 2005-07-05 2007-01-11 President And Fellows Of Harvard College Liver targeted conjugates
AU2007205208B2 (en) * 2006-01-04 2012-11-01 Southern Research Institute Derivatives of sulindac, use thereof and preparation thereof
US20070259829A1 (en) * 2006-03-24 2007-11-08 Maen Abdelrahim Uses of diphenyl/diphenylamine carboxylic acids
US20080261911A1 (en) * 2006-03-24 2008-10-23 Safe Stephen H Uses of diphenyl/diphenylamine carboxylic acids
EP2040699A4 (de) * 2006-06-19 2013-03-13 Vanderbilt University Medical Ct Verfahren und zusammensetzungen für diagnostisches und therapeutisches cox-2-targeting
WO2010019549A2 (en) * 2008-08-12 2010-02-18 Osteogenex Inc Indoprofen derivatives for promoting bone growth
TWI450715B (zh) * 2010-01-08 2014-09-01 Nat Univ Tsing Hua 治療癌症的芬布芬衍生物
CN101897718A (zh) * 2010-07-13 2010-12-01 山东省医学科学院基础医学研究所 一种肿瘤血管生长抑制剂
US20120022116A1 (en) * 2010-07-20 2012-01-26 Huayun Deng Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex
US9346803B2 (en) 2011-10-17 2016-05-24 Vanderbilt University Indomethacin analogs for the treatment of castrate-resistant prostate cancer
EP2623098B1 (de) * 2012-02-03 2016-09-07 King Saud University Amid-Aminosäurenester von nichtsteroidalen entzündungshemmenden Arzneimitteln (NSAIDs) als potente Inhibitoren des Krebszellwachstums

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT290523B (de) 1962-01-05 1971-06-11 Merck & Co Inc Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren
US3336194A (en) 1963-04-30 1967-08-15 Merck & Co Inc Indolyl acid amides
US3285908A (en) 1963-04-30 1966-11-15 Merck & Co Inc Indolyl acid amides
US3654349A (en) 1970-05-01 1972-04-04 Merck & Co Inc Substituted indenyl acetic acids
US3725548A (en) 1970-05-01 1973-04-03 Merck & Co Inc Substituted indenyl acetic acids in the treatment of pain, fever or inflammation
FR2392008A1 (fr) 1977-05-02 1978-12-22 Fabre Sa Pierre Nouvelles formes modulees de medicaments utilisant les n-hydroxy alcoyl pyridine carboxamides comme vecteurs
DE2735537A1 (de) 1977-08-06 1979-02-22 Troponwerke Gmbh & Co Kg Indolacetoxyacetylaminosaeurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPS5490174A (en) 1977-12-27 1979-07-17 Kanebo Ltd Novel indomethacin derivatives and their preparation
US4229447A (en) 1979-06-04 1980-10-21 American Home Products Corporation Intraoral methods of using benzodiazepines
DE2926472A1 (de) 1979-06-30 1981-01-15 Thomae Gmbh Dr K Neue benzoylderivate, deren herstellung und deren verwendung als arzneimittel
US4412994A (en) 1980-04-24 1983-11-01 Interx Research Corporation Mannich-base hydroxamic acid prodrugs, compositions and use
US4381307A (en) 1980-10-31 1983-04-26 Merck & Co., Inc. Soft tertiary amine esters of bio-affecting carboxylic acids
PL131389B1 (en) 1980-11-13 1984-11-30 Krakowskie Zaklady Pharma Method of obtaining n-acyl derivatives of triptamines
DE3145465A1 (de) 1981-11-16 1983-05-19 Krakowskie Zakłady Farmaceutyczne "Polfa", Kraków Verfahren zur herstellung von n-acylderivaten der tryptamine
CA1187488A (en) 1982-02-02 1985-05-21 Yoichiro Ogawa Indoleacetic ester derivatives and process for preparing same
DE3206885A1 (de) 1982-02-26 1983-09-15 Troponwerke GmbH & Co KG, 5000 Köln Indolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPS58201763A (ja) 1982-05-17 1983-11-24 Kowa Co インド−ルアセトキシ酢酸エステル
IL67445A (en) 1982-12-09 1985-11-29 Teva Pharma Ethoxycarbonyloxy ethyl esters of non-steroidal anti-inflammatory carboxylic acids
JPS59161358A (ja) 1983-03-04 1984-09-12 Ss Pharmaceut Co Ltd 新規なインド−ル酢酸エステル誘導体及びその製造法
JPS60112760A (ja) 1983-11-18 1985-06-19 Green Cross Corp:The インド−ル酢酸誘導体及びその脂肪乳剤
JPS60214768A (ja) * 1984-04-07 1985-10-28 Fujisawa Pharmaceut Co Ltd オリゴペプチド化合物
JPS6160649A (ja) 1984-08-31 1986-03-28 Ss Pharmaceut Co Ltd 新規なエステル誘導体及びその製造法
US5016652A (en) 1985-04-25 1991-05-21 The Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
JPS63196598A (ja) 1987-02-09 1988-08-15 Ss Pharmaceut Co Ltd 新規なプレドニゾロンエステル誘導体
JPS63275593A (ja) 1987-05-08 1988-11-14 Fujirebio Inc β−アミノエチルリン酸エステル誘導体
US5002935A (en) 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
DE68906942T3 (de) 1988-03-29 1999-05-12 University Of Florida, Gainesville, Fla. Pharmazeutische Zusammensetzungen für die parenterale Anwendung.
DE3811120A1 (de) 1988-03-31 1989-10-12 Merckle Gmbh Neopentylesterderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4943587A (en) 1988-05-19 1990-07-24 Warner-Lambert Company Hydroxamate derivatives of selected nonsteroidal antiinflammatory acyl residues and their use for cyclooxygenase and 5-lipoxygenase inhibition
US5504086A (en) 1989-10-17 1996-04-02 Ellinwood, Jr.; Everett H. Intraoral dosing method of administering trifluorobenzodiazepines, propoxyphene, and nefazodone
US5032588A (en) 1989-12-08 1991-07-16 Abbott Laboratories Thiazole lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids
US5681964A (en) 1990-10-23 1997-10-28 University Of Kentucky Research Foundation Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
US6048850A (en) 1992-09-22 2000-04-11 Young; Donald A. Method of inhibiting prostaglandin synthesis in a human host
US5436265A (en) 1993-11-12 1995-07-25 Merck Frosst Canada, Inc. 1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents
JPH09501655A (ja) 1993-08-02 1997-02-18 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼーション 治療化合物−脂肪酸接合体
CA2182228C (en) 1994-01-28 2008-09-16 Paul Ashton Codrugs as a method of controlled drug delivery
ATE170839T1 (de) * 1994-02-22 1998-09-15 Merrell Pharma Inc Indolderivate zur behandlung von östrogenabhängigen neoplasmen und krankheiten
US5607966A (en) 1994-12-23 1997-03-04 Alcon Laboratories, Inc. Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory prodrugs
US5643943A (en) 1994-12-23 1997-07-01 Alcon Laboratories, Inc. Systemic administration of esters and amides of antioxidants which may be used as antioxidant prodrug therapy for oxidative and inflammatory pathogenesis
US5510368A (en) * 1995-05-22 1996-04-23 Merck Frosst Canada, Inc. N-benzyl-3-indoleacetic acids as antiinflammatory drugs
GB2321455A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds

Also Published As

Publication number Publication date
US6207700B1 (en) 2001-03-27
EP1146788A1 (de) 2001-10-24
EP1146788B1 (de) 2007-05-23
DE69936150D1 (de) 2007-07-05
DE69936150T2 (de) 2008-01-31
ATE362758T1 (de) 2007-06-15
AU760555B2 (en) 2003-05-15
CA2358289C (en) 2009-12-08
CN1195515C (zh) 2005-04-06
IL144127A (en) 2006-12-10
US6399647B2 (en) 2002-06-04
CA2358289A1 (en) 2000-07-13
EP1146788A4 (de) 2003-09-10
AU2369800A (en) 2000-07-24
CN1337850A (zh) 2002-02-27
BR9916800A (pt) 2001-10-23
ES2288039T3 (es) 2007-12-16
JP2002534362A (ja) 2002-10-15
WO2000040088A1 (en) 2000-07-13
US20010034361A1 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
IL144127A0 (en) Pharmaceutical compositions containing a carboxylic acid secondary amide derivative
UA40663C2 (uk) Тверда фармацевтична композиція з регульованим вивільненням лікарського засобу для орального вживання
TR199801115T2 (xx) Kinazolin t�revleri.
GB9914486D0 (en) Medicaments
MXPA03000820A (es) Compuestos terapeuticos de polianhidrido para suministro de farmacos.
TR199801530T2 (xx) VEGF �nhibit�rleri olarak kinazolin t�revleri.
EE200100558A (et) Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine
MXPA05002871A (es) Derivados de benzodiazaepina y composiciones farmaceuticas que los contienen.
BR9904998A (pt) Derivados de hidroxamida do ácido 5-oxo-pirrolidina-2-carboxìlico
MY128659A (en) Novel aminodicarboxylic acid derivatives having pharmaceutical properties
CA2478374A1 (en) N3 alkylated benzimidazole derivatives as mek inhibitors
NZ279062A (en) Use of phenylazosalicylic acid derivatives for treatment/prevention of colon cancer
EP2168964A4 (de) Gekoppelte azaindol-indol-derivate, herstellungsverfahren und anwendungen davon
AU8830801A (en) Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
MXPA05009611A (es) Piperidinas sustituidas como nuevos inhibidores de mdm2-p53.
DE69709493D1 (de) Substituierte Indazolderivate
EP1678162A4 (de) P-glycoprotein-inhibitor, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die diesen enthält
ES2185911T3 (es) Composiciones farmaceuticas que contienen polimeros de ortoester tamponados.
TR199900336T2 (xx) EAA antagonistleri olarak tetrahidrokinolin t�revleri.
PL342614A1 (en) Anticarcinogenic drugs
EP1109560A4 (de) Als inhibitoren der aicarftnützliche verbindungen
CY1112057T1 (el) Θεραπευτικος παραγων για διαταραχη επαρκειας τροφης στο στομαχι
TW200744583A (en) Statin stabilizing dosage formulations
DE60024648D1 (de) Carbonsäuren und acylsulfonamide, diese verbindungen enthaltende zubereitungen und behandlungsmethoden
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed